Literature DB >> 34039021

Homocysteine Is Associated With Future Venous Thromboembolism in 2 Prospective Cohorts of Women.

Aaron W Aday1,2, Edward K Duran1,3, Martin Van Denburgh1, Eunjung Kim1, William G Christen1, JoAnn E Manson1, Paul M Ridker4, Aruna D Pradhan5.   

Abstract

[Figure: see text].

Entities:  

Keywords:  biomarker; homocysteine; plasma; pulmonary embolism; venous thromboembolism

Mesh：

Substances：

Year:  2021        PMID： 34039021      PMCID： PMC8222168          DOI： 10.1161/ATVBAHA.121.316397

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   10.514


  43 in total

1.  Fasting vs nonfasting plasma homocysteine concentrations for diagnosis of hyperhomocysteinemia.

Authors:  M Rebecca Fokkema; Marleen F Gilissen; Jasper J Van Doormaal; Marcel Volmer; Ido P Kema; Frits A J Muskiet
Journal:  Clin Chem       Date:  2003-05       Impact factor: 8.327

2.  Homocysteine and short-term risk of myocardial infarction and stroke in the elderly: the Rotterdam Study.

Authors:  M L Bots; L J Launer; J Lindemans; A W Hoes; A Hofman; J C Witteman; P J Koudstaal; D E Grobbee
Journal:  Arch Intern Med       Date:  1999-01-11

Review 3.  Homocysteine and atherothrombosis.

Authors:  G N Welch; J Loscalzo
Journal:  N Engl J Med       Date:  1998-04-09       Impact factor: 91.245

4.  Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism.

Authors:  P M Ridker; C H Hennekens; J Selhub; J P Miletich; M R Malinow; M J Stampfer
Journal:  Circulation       Date:  1997-04-01       Impact factor: 29.690

5.  Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia.

Authors:  R T Eberhardt; M A Forgione; A Cap; J A Leopold; M A Rudd; M Trolliet; S Heydrick; R Stark; E S Klings; N I Moldovan; M Yaghoubi; P J Goldschmidt-Clermont; H W Farber; R Cohen; J Loscalzo
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

6.  Serum homocysteine, thermolabile variant of methylene tetrahydrofolate reductase (MTHFR), and venous thromboembolism: Longitudinal Investigation of Thromboembolism Etiology (LITE).

Authors:  Albert W Tsai; Mary Cushman; Michael Y Tsai; Susan R Heckbert; Wayne D Rosamond; Nena Aleksic; N David Yanez; Bruce M Psaty; Aaron R Folsom
Journal:  Am J Hematol       Date:  2003-03       Impact factor: 10.047

7.  A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.

Authors:  Paul M Ridker; Nancy R Cook; I-Min Lee; David Gordon; J Michael Gaziano; Joann E Manson; Charles H Hennekens; Julie E Buring
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

8.  Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis.

Authors:  L A Harker; R Ross; S J Slichter; C R Scott
Journal:  J Clin Invest       Date:  1976-09       Impact factor: 14.808

9.  C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women.

Authors:  Paul M Ridker; Julie E Buring; Nancy R Cook; Nader Rifai
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

10.  Genetic Analysis of Venous Thromboembolism in UK Biobank Identifies the ZFPM2 Locus and Implicates Obesity as a Causal Risk Factor.

Authors:  Derek Klarin; Connor A Emdin; Pradeep Natarajan; Mark F Conrad; Sekar Kathiresan
Journal:  Circ Cardiovasc Genet       Date:  2017-04
View more
  2 in total

1.  A Case of Portal Vein Thrombosis in a Patient With Methylenetetrahydrofolate Reductase A1298C Polymorphism.

Authors:  Anna Martin; Sierra Struble; Antonio Prado; Jacob Robinson; John Goddard; Travis Smith
Journal:  Cureus       Date:  2022-01-30

2.  High penetrance, recurrent attacks and thrombus formation in a family with hereditary coproporphyria.

Authors:  Cindy Towns; Sobana Balakrishnan; Chris Florkowski; Andrew Davies; Elaine Barrington-Ward
Journal:  JIMD Rep       Date:  2022-03-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.